Evidence map›Paper›PMID 18649061›Full record

ArticleHeart and vessels2008

A significant interaction between moxifloxacin and warfarin in a patient with a mitral bioprosthetic valve.

Fatih Yildiz, Behice Kurtaran, Murat Cayli, Aslihan Candevir, Zehra Sümbül

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Heart and vessels, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Moxifloxacin-warfarin interaction.Journal of community hospital internal medicine perspectives · 2011
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Fatih YildizDepartment of Internal Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey. drcayli@yahoo.com
Behice Kurtaran
Murat Cayli
Aslihan Candevir
Zehra Sümbül
Cukurova University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Moxifloxacin is an advanced-generation fluoroquinolone with a broad spectrum of antimicrobial activity that is not metabolized by cytochrome P450 system. Therefore, the drug interaction of moxifloxacin is rarely seen. It has been reported that moxifloxacin is safe and well tolerable. We aimed to report a drug interaction between moxifloxacin and warfarin in a 74-year-old patient with a prosthetic mitral valve.

Indexed as

BioprosthesisHeart Valve ProsthesisAgedAnticoagulantsAnti-Infective AgentsAza CompoundsBlood CoagulationBlood Component TransfusionDrug InteractionsEndocarditisFluoroquinolonesHeart Valve Prosthesis ImplantationHumansInternational Normalized RatioMaleMitral ValveAnticoagulantsAnti-Infective AgentsAza CompoundsFluoroquinolonesMoxifloxacinQuinolinesWarfarin

Identifiers

PMID18649061
OpenAlexW2149568211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.